A post market registry to understand the his bundle pacing (HBP) workflow in routine practice.

Not Applicable

Conditions: Health Condition 1: I440- Atrioventricular block, first degreeHealth Condition 2: I501- Left ventricular failure, unspecified

Registration Number: CTRI/2019/04/018796

Lead Sponsor: St Jude Medical India Pvt Ltd Abbott

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Subjects must meet the following inclusion criteria for enrollment in the registry.

1. Scheduled for implantation of a de novo Abbott pacemaker, defibrillator, or CRT-P/D device with a pacing lead located at the His bundle according to the clinical siteâ??s routine care

2. At least 18 years of age

3. Willing and able to comply with the prescribed follow-up tests and schedule of evaluations

4. Provided written informed consent prior to any registry-related procedures

Exclusion Criteria

Subjects will be excluded from enrollment if any of the exclusion criteria is met below.

1. History of tricuspid valve repair or replacement

2. Currently participating in another clinical study with an active treatment arm and belong to the active arm

3. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigatorâ??s opinion, could limit the subjectâ??s ability to participate in the registry or to comply with follow-up requirements, or impact the scientific soundness of the registry results

4. Previous failed HBP implant

5. Life expectancy of less than 6 months

6. Known contraindication for an HBP implant (i.e. ongoing infection, known inclusion of the subclavian vein, etc.)

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Implant and follow-up characteristics will be compared with and without utilizing the EnSite Cardiac Mapping System during HBP device implants.Timepoint: Implant and 6-Month Follow-Up

Secondary Outcome Measures